Prostate cancer metastatic

• A Study to Learn About the Investigational Medicine Called PF-06821497 (mevrometostat) in Men with mCRPC Who Were Previously Treated with Ab … Recruitment ended
  2024-511650-50-00 5 2025-01-17 "METASTATIC CASTRATION RESISTANT PROSTATE CANCER"
• A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer Recruitment ended
  2024-511038-11-00 4 2024-09-24 "advanced prostate cancer"
• A randomised, phase 3 trial comparing 3-weekly docetaxel 75 mg/m2 versus 2-weekly Docetaxel 50 mg/m2 in combination with Darolutamide + ADT … Recruitment ended
  2022-502634-52-00 5 2023-05-16 "prostate cancer"
• A Phase 1/2a study of PF-07220060 in Participants with Advanced Solid Tumors Recruitment ended
  2024-512120-11-00 7 2022-08-31 "Part 2A, 2B, 2C & 2E HR-positive /HER2-negative breast cance"
• A trial to learn how well capivasertib with docetaxel works and how safe it is in people with metastatic castration-resistant prostate cance … Recruitment ended
  2023-504996-26-00 5 2022-07-21 "Metastatic Castration Resistant Prostate Cancer (mCRPC)"
• Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer (PETRANHA) Recruitment ended
  2023-508536-64-00 9 2022-05-17 "Metastatic Prostate Cancer"
• An International, Randomized, Double-Blind, Phase III Study of Fuzuloparib Combined with Abiraterone Acetate and Prednisone (AA-P) versus Pl … Recruitment ended
  2023-509396-16-00 5 2021-11-08 "Metastatic Castration-Resistant Prostate Cancer"
• Phase 3 Randomized Study of Talazoparib with Enzalutamide in Men with DDR Gene Mutated mCSPC Recruitment ended
  2024-510809-28-00 5 2021-09-27 "Metastatic Castration-sensitive Prostate Cancer"
• A Phase 3 Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment … Recruitment ended
  2023-506365-64-00 5 2020-10-16 "Deleterious Germline or Somatic Homologous Recombination Rep"
• TALAPRO 2: A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY OF TALAZOPARIB WITH ENZALUTAMIDE IN METASTATIC CASTRATION RESISTANT … Recruitment ended
  2023-509087-20-00 5 2019-04-16 "Metastatic Castration-resistant Prostate Cancer"
• A Phase 3 Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment … Recruitment ended
  2023-503254-12-00 5 2019-03-06 "Metastatic Prostate Cancer"
• A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study Recruitment ended
  2023-510298-33-00 4 2016-11-29 "Prostate Cancer"
• A Study of Apalutamide Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants with mHSPC Recruitment ended
  2023-508607-20-00 5 2015-11-27 "Metastatic Hormone-sensitive Prostate Cancer"
• A Randomized multicenter phase III trial comparing enzalutamide vs. a combination of Ra223 and enzalutamide in asymptomatic or mildly sympto … Recruitment ended
  2023-510453-41-00 5 2015-10-26 "Castration resistant prostate cancer patients metastatic to "
• An Efficacy and Safety Study of JNJ56021927 in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC) Recruitment ended
  2023-508606-26-00 5 2015-04-23 "Metastatic castration-resistant prostate cancer (mCRPC)"
• A Clinical study to assess the safety and effectiveness of ARN-509 in men with Castration-Resistant Prostate Cancer (prostate cancer not res … Recruitment ended
  2023-509221-47-00 5 2014-02-12 "Castration-Resistant Prostate Cancer"
• A dose-escalation and expansion study of the safety and pharmacokinetics of XB002 as single-agent and combination therapy in subjects with i … Ended
  2023-508267-69-00 3 2023-08-11 "Subjects with Aadvanced solid tumors for whom life-prolongin"
• MK-5684 Food Effect Study Ended
  2023-505521-14-00 3 2023-08-02 "refractory metastatic prostate cancer"
• A Phase 1b Open-Label, Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of ARV-110 in Combination with Abiraterone … Ended
  2024-516661-37-00 3 2022-07-27 "Metastatic Prostate Cancer"
• LAVA1207-001/LAVA1207-002 A Phase 1 and 2a open-label trial to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immun … Ended
  2024-515821-27-00 9 2021-11-30 "Prostate Cancer"
• A trial to learn how well darolutamide plus androgen deprivation therapy (ADT) works in comparison to placebo plus ADT in men with prostate … Ended
  2022-502244-12-00 5 2021-02-22 "Metastatic hormone-sensitive prostate cancer (mHSPC)"
• Phase 3 Study of Pembrolizumab plus Enzalutamide in mCRPC Ended
  2022-500785-10-00 5 2019-08-23 "Metastatic Castration-Resistant Prostate Cancer"
• Study of Nivolumab plus Ipilimumab, Ipilimumab or Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer Ended
  2022-502909-15-00 4 2017-06-09 "Metastatic Castration-Resistant Prostate Cancer"

Showing 25–47 of 47 trials